Health
A SARS-CoV-2 vaccine candidate based on B.1.351 spike trimer shows broad neutralizing capability – News-Medical.Net
Researchers tested the vaccine candidate in mice with up to three doses and found it produces high levels of antibodies against both SARS-CoV-2 variants of concern…
Researchers tested a vaccine candidate in mice with up to three doses and found it produces high levels of antibodies against both SARS-CoV-2 variants of concern and the original virus strain.
The emergence of several new mutations of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to concerns about increased transmissibility of the virus and the ability of vaccines to protect against them. Some studies point to lower efficacy of vaccines to the new strains compared to…
-
Business22 hours agoDoes Macquarie rate Rio Tinto shares a buy, hold or sell after its big news?
-
Business22 hours agoThese 2 ASX 200 blue-chip stocks just hit new record highs
-
Noosa News23 hours agoLeague blocked trades that didn’t benefit expansion clubs claims former AFLW coach Nathan Burke
-
Noosa News22 hours agoThe ‘architect of modern Queensland’ farewelled in Brisbane